Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Aug 19, 2022

Accession no.
0001209191-22-046900
Filed
Aug 19, 2022
Trade date
Jul 1-Aug 15, 2022
Filing delay
49 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 28 non-derivative transactions. Open-market purchases total $1.57K. It was filed 49 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2022Common StockPPurchaseAcquired+20$2.11+$42.217,024Direct
Jul 5, 2022Common StockPPurchaseAcquired+27$2.18+$58.8617,051Direct
Jul 6, 2022Common StockPPurchaseAcquired+27$2.11+$56.9717,078Direct
Jul 7, 2022Common StockPPurchaseAcquired+27$2.18+$58.8617,105Direct
Jul 8, 2022Common StockPPurchaseAcquired+27$2.21+$59.6717,132Direct
Jul 12, 2022Common StockPPurchaseAcquired+27$2.25+$60.7517,159Direct
Jul 14, 2022Common StockPPurchaseAcquired+27$2.28+$61.5617,186Direct
Jul 15, 2022Common StockPPurchaseAcquired+27$2.23+$60.2117,213Direct
Jul 18, 2022Common StockPPurchaseAcquired+24$2.41+$57.8417,237Direct
Jul 19, 2022Common StockPPurchaseAcquired+24$2.47+$59.2817,261Direct
Jul 20, 2022Common StockPPurchaseAcquired+24$2.52+$60.4817,285Direct
Jul 21, 2022Common StockPPurchaseAcquired+24$2.54+$60.9617,309Direct
Jul 22, 2022Common StockPPurchaseAcquired+24$2.53+$60.7217,333Direct
Jul 25, 2022Common StockPPurchaseAcquired+24$2.48+$59.5217,357Direct
Jul 26, 2022Common StockPPurchaseAcquired+24$2.47+$59.2817,381Direct
Jul 27, 2022Common StockPPurchaseAcquired+19$2.36+$44.8417,400Direct
Jul 28, 2022Common StockPPurchaseAcquired+24$2.28+$54.7217,424Direct
Jul 29, 2022Common StockPPurchaseAcquired+24$2.28+$54.7217,448Direct
Aug 1, 2022Common StockPPurchaseAcquired+24$2.34+$56.1617,472Direct
Aug 3, 2022Common StockPPurchaseAcquired+12$2.45+$29.417,484Direct
Aug 4, 2022Common StockPPurchaseAcquired+24$2.17+$52.0817,508Direct
Aug 5, 2022Common StockPPurchaseAcquired+24$2.12+$50.8817,532Direct
Aug 8, 2022Common StockPPurchaseAcquired+26$2.19+$56.9417,558Direct
Aug 9, 2022Common StockPPurchaseAcquired+26$2.19+$56.9417,584Direct
Aug 10, 2022Common StockPPurchaseAcquired+26$2.19+$56.9417,610Direct
Aug 11, 2022Common StockPPurchaseAcquired+26$2.46+$63.9617,636Direct
Aug 12, 2022Common StockPPurchaseAcquired+26$2.52+$65.5217,662Direct
Aug 15, 2022Common StockPPurchaseAcquired+20$2.45+$4917,682Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)